atorvastatin has been researched along with Chronic Primary Open Angle Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cheng, Y; Gong, B; He, S; Huo, Y; Lin, Y; Luo, Q; Shuai, P; Sun, X; Tai, Z; Wang, J; Wang, X; Xu, Y; Xue, B; Yan, B; Yang, F; Yang, J; Yang, Z; Yin, Y; Yu, M; Zhang, H; Zhang, J; Zhang, L; Zhou, Y; Zhu, X; Zou, T | 1 |
| Musch, DC; Stein, JD; Talwar, N | 1 |
2 other study(ies) available for atorvastatin and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Cholesterol homeostasis regulated by ABCA1 is critical for retinal ganglion cell survival.
Topics: Animals; Artificial Intelligence; Atorvastatin; ATP Binding Cassette Transporter 1; Cell Line; Cholesterol; Genome-Wide Association Study; Glaucoma, Open-Angle; Homeostasis; Mice; Retinal Ganglion Cells | 2023 |
Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma.
Topics: Aged; Atorvastatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Intraocular Pressure; Male; Prognosis; Retrospective Studies; Risk Factors | 2017 |